StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research note released on Friday morning. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Trading Up 34.7 %
Shares of CO stock opened at $2.99 on Friday. Global Cord Blood has a 12-month low of $2.03 and a 12-month high of $5.50. The stock has a market capitalization of $363.44 million, a P/E ratio of 2.73 and a beta of 0.16. The firm’s 50 day moving average is $1.52 and its 200 day moving average is $1.35.
Global Cord Blood Company Profile
Recommended Stories
- Five stocks we like better than Global Cord Blood
- How to Invest in Small Cap Stocks
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- Buy P&G Now, Before It Sets A New All-Time High
- CarMax’s Impressive Rally: What Investors Should Watch Next
- What is the Dow Jones Industrial Average (DJIA)?
- MarketBeat Week in Review – 9/23 – 9/27
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.